TB Resources

TB GUIDES

Provisional CDC Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease

Severe COVID-19: A TB Risk Factor

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment

Human rights, informed consent, and high ethical standards as a basis for people-centered TB care

Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide

Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis

Practical manual of processing stool samples for diagnosis of childhood TB

Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians

WHO issues Information Note on ensuring continuity of essential TB services for people with or at risk of the disease in Ukraine and refugee-hosting countries

Virtual Meeting of the Global Multisectoral and Multi-stakeholder Platform to end TB

How to Treat Drug-Resistant Tuberculosis

Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing

Tuberculosis in the time of COVID-19

Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing

Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine

Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex

Managing Drug Interactions in HIV and TB Coinfection Is Complex

Information sheet: Management of tuberculosis in children and adolescents

WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents

WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents

An Activist’s Guide to Rifapentine for the Treatment of TB Infection

Clinical standards for the diagnosis, treatment and prevention of TB infection

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022

TB Provider Toolkit

Clinical standards for the diagnosis, treatment and prevention of TB infection

Building Resilience: Keeping Mentally Healthy to Keep Moving Forward

New American Academy of Pediatrics statement on testing for and treating TB infection in children: Tuberculosis Infection in Children and Adolescents: Testing and Treatment

The Mantoux Tuberculin Skin Test Wall Chart

CDC - Patient Education Materials Series

CDC - Tuberculosis: The Connection between TB and HIV

CULTURAL QUICK REFERENCE GUIDE: AFGHANISTAN

TB REPORTS

WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update

1/4/6×24 Campaign

Pipeline Report » 2022 : Tuberculosis Diagnostics

WHO Global Tuberculosis Report 2022

TAG's 2022 Pipeline Report: The latest TB vaccine research

Framework for collaborative action on tuberculosis and comorbidities

Health systems in crisis: The Global Fund's impact in Ukraine

DIGITAL TB SURVEILLANCE SYSTEM ASSESSMENT REPORT

Consolidated report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services

Friends of the Global Fight Investment Case

The impact of COVID-19 on TB: a review of the data

TB Elimination Alliance Impact Report 2020-2021

TAG - 2021 TB Pipeline Report

Stop TB Partnership - EXECUTIVE BRIEF: Key Findings and Calls to Action

Stop TB Partnership - Civil Society Report on TB and COVID

DevPolicy Blog - Progress towards ending TB at risk

FACT SHEET: The Biden Administration’s Commitment to Global Health

TUBERCULOSIS RESOURCES

TB VACCINES

Clinical trials of new BCG vaccine for TB to start soon, says former CSIR chief

Effect of BCG on Respiratory Complications Caused by COVID-19: A Scoping Review

Analyzing TB T-cell response gives clues to vaccines, and TB itself

Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge

Could a 100-year-old TB vaccine help scientists find a better one?

Is There a Vaccine for Tuberculosis (TB)?

Diversifying the next generation of TB vaccines

Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel

Bacterial vaccines in clinical and preclinical development 2021: An overview and analysis

Can a Recombinant BCG Vaccine Better Protect HIV-Positive Children?

ICMR to begin study to evaluate BCG booster dose for kids, adolescents

Does BCG vaccination protect against infection with M. tuberculosis?

Inhaled vaccine for COVID-19: The pandemic accelerated decades of research leading to jab-free vaccine now in human testing

Delayed Adaptive Immune Response to Tuberculosis Points to Vaccination Strategies

Can we improve on a once-in-a-century TB vaccine?

Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro

Preparing For TB, Polio, Measles, and COVID-19 Outbreaks

WHO calls for urgent BCG alternative

Good and bad news about new TB vaccines

The Scientist - Infographic: TB Vaccines in the Pipeline Take Varied Approaches

Stop TB Partnership - STATEMENT ON BCG VACCINATION AND COVID-19 New Tools Working Groups

TB 101

Understanding the Connection Between HIV and Tuberculosis

Global TB Caucus: TB video series

How to Protect Ourselves from TB

Common Budgetary Terms Explained

NCHHSTP Metrics Dashboard: TB Elimination

Global Health Impact Index

How Tuberculosis Spreads (video)

The Scientist - Tuberculosis: The Forgotten Pandemic

TAG - 2021 TB Pipeline Report

WHO - Tuberculosis

CDC - Tuberculosis

Where we unite to #EndTB!

Find TB and COVID resources on our TB & COVID page here!

Where we unite to #EndTB!

Stop TB USA